Regulation of innate and adaptive immune responses in xenotransplantation by modulating CD47sirp α signaling
Regulation of innate and adaptive immune responses in xenotransplantation by modulating CD47sirp α signaling
批准号:
18390348
负责人:
OHDAN Hideki
金额:
$10.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
巨噬细胞诱导的细胞毒性与异种移植物的长期存活有关,但其机制尚不清楚。最近的报道表明信号调节蛋白(SIRP)α是巨噬细胞上的一种重要的免疫抑制受体,其与SIRPα的配体CD 47的相互作用阻止自体吞噬。我们证实,种间不相容性的CD 47显着有助于异种细胞的排斥巨噬细胞。在猪细胞上遗传诱导人CD 47可以提供对人巨噬细胞上SIRPα的抑制性信号,为预防巨噬细胞介导的异种移植排斥提供了一种新的方法。CD 47-SIRPα信号系统在获得性免疫应答中也可能发挥重要作用。我们已经分析了频率和增殖活性的人T细胞响应无论是猪或同种异体PBMC通过使用体外混合淋巴细胞反应(MLR)与CFSE标记技术测定。频率 ...更多信息 同种异体反应性和异种反应性CD 4 ^+ T细胞前体的反应几乎相同,但是异种反应性CD 4 ^+ T细胞的刺激指数(SI)显著高于同种异体反应性,表明单个异种反应性CD 4 ^+ T细胞的反应更强。此外,当在MLR中从应答者中去除CD 4 ^+ T细胞时,异种反应性CD 8 ^+ T细胞的增殖显著低于同种异体反应性CD 8 ^+ T细胞,这表明人CD 4 ^+ T细胞而不是CDS,T细胞足以诱导猪异种移植排斥反应。此外,异种反应性CDC和CostT细胞的SI在人CD 47-Fc的存在下也被显著抑制。这些结果表明,由于CD 47的种间不相容性,人T细胞对猪细胞的反应比对同种异体细胞的反应更强。此外,基因操作猪细胞诱导人CD 47表达可能会减弱人T细胞介导的异种移植排斥反应。少
英文摘要
It has been reported that macrophage-induced cytotoxicity is involved in lon-term xenograft survival, however, the mechanism has remained unknown. A recent report indicates that the signal regulatory protein (SIRP) α is a critical immune inhibitory receptor on macrophages, and its interaction with CD47, a ligand for SIRPα, prevents autologous phagocytosis. We confirmed that interspecies incompatibility of CD47 significantly contributes to the rejection of xenogeneic cells by macrophages. Genetic induction of human CD47 on porcine cells could provide inhibitory signaling to SIRPα on human macrophages, providing a novel approach to preventing macrophage-mediated xenograft rejection. CD47-SIRPα signaling system may also play an important role in adaptive immune response. We have analyzed the frequency and proliferative activity of human T cells responding to either porcine or allogenic PBMCs by using in vitro mixed lymphocyte reaction (MLR) assay with a CFSE-labeling technique. The freque … More ncies of alloreactive and xenoreactive CD4^+ T cell precursors were almost identical, however, the Stimulation Index (SI) of xenoreactive CD4^+ T cells was significantly higher than that of alloreactive, indicating a stronger reaction by a single xenoreactive CD4^+ T cell. Moreover, when CD4^+ T cells were depleted from the responders in the MLR, the proliferation of xenoreactive CD8^+ T cells was significantly less than that of alloreactive CD8^+ T cells, indicating that the human CD4^+ T cells, but not CDS, T cells, are sufficient to induce porcine xenograft rejection. Further, The SI of xenoreactive CDC and Cost T cells was also significantly suppressed in the presence of human CD47-Fc. These results suggest that the human T cell responses to porcine cells are stronger than those to allogeneic cells because of the interspecies incompatibility of CD47. Moreover, genetic manipulation of porcine cells to induce human CD47 expression might attenuate human T cell-mediated xenograft rejection. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Characterization of anti-Gal antibody-producing cells of baboons and humans
狒狒和人类抗 Gal 抗体产生细胞的表征
DOI:
--
发表时间:
2006
期刊:
Transplantation 27, 81(6)
影响因子:
--
作者:
[Y.,Xu, Y.,C.,Yang, H.,Ohdan, D.Ryan,D.,Harper, C.Wu, H.S.,Kruge-Grey, A.D.Thall, M., Awwad, M., Sykes]
通讯作者:
Sykes
Liver sinusoidal endothwlial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity
内吞同种异体细胞的肝窦内皮细胞以间接同种异体特异性抑制 T 细胞
DOI:
--
发表时间:
2006
期刊:
The Journal of Immunology 177・6
影响因子:
--
作者:
[Tokita Daisuke, et al.]
通讯作者:
et al.
Mechanism of avoidance of xenogeneic rejection by macrophages through intracellular inhibitory CD47-SHIPα signaling
通过细胞内抑制性 CD47-SHIPα 信号传导避免巨噬细胞异种排斥的机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[K., Ide, H., Ohdan, H., Tahara, N., Basnet, K.,Ishiyama, Y., Tanaka, M., Shishida, T., Irei, M., Ohira, Y., Igarashi, T., Asahara]
通讯作者:
Asahara
Human CD47 expression protects porcine cells from xenogeneic human macrophage phagocyrtosis through inhibitory CD47-S1RPα signaling
人 CD47 表达通过抑制性 CD47-S1RPα 信号传导保护猪细胞免受异种人巨噬细胞吞噬作用
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[K., Ide, H., Wang, T., Asahara, M., Sykes, Y.G., Yang, H., Ohdan]
通讯作者:
Ohdan
Immunogenicity of xenogeneic antigen N-glycolylneuraminic acid (NeuGc)
异种抗原 N-羟乙酰神经氨酸 (NeuGc) 的免疫原性
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[H., Tahara, H., Ohdan, K., Ide, N., Basnet, K., Ishiyama, M., Shishida, Y., Tanaka, T., Irei, M., Ohira, Y., Igarashi, M., Doskali, H., Takematsu, Y., Kozutsumi, T., Asahara]
通讯作者:
Asahara
共 25 条
Development of a novel desensitization/immune-regulatory method by use of multi-potent suppressor B cells to induce immune-tolerance in allogeneic organ transplantation
-
批准号:15H02555
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.62万
-
财政年份:2015
-
负责人:OHDAN Hideki
-
依托单位:
Development of novel cell therapeutic strategy using unlicenced NK cells combined with molecular target medicine for liver cancer
-
批准号:25670581
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:OHDAN Hideki
-
依托单位:
The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells
-
批准号:23249064
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.87万
-
财政年份:2011
-
负责人:OHDAN Hideki
-
依托单位:
Establishment of strategies to regulate antibody-mediated rejection on the basis of B cell differentiation biology
-
批准号:23659614
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:OHDAN Hideki
-
依托单位:
Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling
-
批准号:20390344
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:OHDAN Hideki
-
依托单位:
Elucidation of mechanisms for macrophage-mediated xenograft refection and a novel approach to prevent macrophage-mediated xenograft rejection by gene introduction of human CD47 to xenogenic cells
-
批准号:16591257
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:OHDAN Hideki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
-
批准号:82372160
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈峰
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
-
批准号:81102247
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:丁晨光
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位: